Mucopenetration study of solid lipid nanoparticles containing magneto sensitive iron oxide

Area of Science:

• Nanomedicine
• Respiratory Medicine
• Biomaterials Science

Background:

• Chronic respiratory diseases feature viscous airway secretions that impede drug delivery systems (DDSs).
• Existing mucopenetration strategies, like PEGylation, show reduced efficacy in complex airway mucus.
• Targeting airway epithelium in conditions like COPD requires overcoming the mucus barrier.

Purpose of the Study:

• To evaluate magnetic PEGylated Solid Lipid Nanoparticles (mSLNs) for enhanced mucopenetration in COPD airway secretions.
• To investigate the influence of mucus mesostructure and magnetic fields on mSLN permeability.
• To assess the adhesion of mSLNs to airway epithelial cells (AECs).

Main Methods:

• Investigated mSLN permeability through COPD sputum, high (HI) and low (LO) airway secretions, and porcine gastric mucus (PGM) under a magnetic field.
• Performed rheological tests to characterize mucus properties.
• Assessed mSLN adhesion to AECs.

Main Results:

• mSLNs demonstrated permeability in COPD sputum and PGM, but not in HI or LO secretions.
• Rheological findings indicated differing elastic properties correlating with mucus mesostructures.
• Magnetic field application improved mSLN adhesion to AECs.

Conclusions:

• Mucus mesostructure is a critical determinant of mSLN mucopenetration.
• mSLNs show potential for overcoming airway mucus barriers in specific COPD contexts.
• Magnetic guidance offers a strategy to enhance nanoparticle interaction with target cells.